Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn’s Disease and Ulcerative Colitis

Abstract: Patients with Crohn’s disease (CD) or ulcerative colitis (UC) have high morbidity rates owing to debilitating intestinal complications and extraintestinal manifestations (EIMs). We retrospectively identified […]

Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel Disease

Abstract: In recent years, knowledge about the pathophysiology of inflammatory bowel disease (IBD) has led to the development of novel therapies and biologics with differing mechanisms […]

Advances in the Diagnosis and Management of Pancreatic Cysts

G&H  Why should physicians be vigilant for pancreatic cysts? AML  Ninety percent of patients in whom pancreatic cancer is diagnosed will die within 5 years. Studies […]

Overview of Total Parenteral Nutrition in Patients With Inflammatory Bowel Disease

G&H  How often does malnutrition occur in the setting of inflammatory bowel disease?  HB  Malnutrition is very prevalent among patients with inflammatory bowel disease (IBD). It […]

Neuromodulation and Neurostimulation for the Treatment of Functional Gastrointestinal Disorders

G&H  What are the general mechanisms of action of electroneuromodulation for functional gastrointestinal disorders? JC  Motility dysfunction is one of the major problems in patients with […]

Insights on the Risk of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis

G&H  What is the prevalence of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis?  AS  Hepatocellular carcinoma (HCC) is the 7th most common cancer worldwide, with approximately […]

Letter From the Editor: Spotlight on Inflammatory Bowel Disease

Gary R. Lichtenstein, MD, AGAF, FACP, FACG

The most recent estimates suggest that 3.1 million, or 1.3%, of US adults have been diagnosed with inflammatory bowel disease (IBD; Crohn’s disease or ulcerative colitis) […]

Back to Archive
Millennium Medical Publishing, Inc